March 19, 2019
Arix Bioscience invests in sickle cell disease specialist Imara
Arix Bioscience has invested in new portfolio company Imara, Inc, thus adding to its novel therapeutics for chronic treatment of Sickle Cell Disease (SCD) and other hemoglobinopathies options.